TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology
- PMID: 35816404
- PMCID: PMC9836373
- DOI: 10.1111/bpa.13108
TREM2-induced activation of microglia contributes to synaptic integrity in cognitively intact aged individuals with Alzheimer's neuropathology
Abstract
The existence of individuals who remain cognitively intact despite presenting histopathological signs of Alzheimer's disease (AD), here referred to as "Nondemented with AD neuropathology" (NDAN), suggests that some mechanisms are triggered to resist cognitive impairment. Exposed phosphatidylserine (ePS) represents a neuronal "eat-me" signal involved in microglial-mediated phagocytosis of damaged synapses. A possible mediator of this process is TREM2, a microglial surface receptor activated by ligands including PS. Based on TREM2 role in the scavenging function of microglia, we hypothesize that an efficient microglial phagocytosis of damaged synapses underlies synaptic resilience in NDAN, thus protecting from memory deficits. Using immunofluorescence microscopy, we performed a comparative study of human post-mortem frontal cortices of aged-matched, AD and NDAN individuals. We studied the distribution of activated microglia (IBA1, IBA1+ /CD68+ cells) and phagocytic microglia-related proteins (TREM2, DAP12), demonstrating higher microglial activation and TREM2 expression in NDAN versus AD. A study of the preservation of synapses around plaques, assessed using MAP2 and βIII tubulin as dendritic and axonal markers, respectively, and PSD95 as a postsynaptic marker, revealed preserved axonal/dendritic structure around plaques in NDAN versus AD. Moreover, high levels of PSD95 around NDAN plaques and the colocalization of PSD95 with CD68 indicated a prompt removal of damaged synapses by phagocytic microglia. Furthermore, Annexin V assay on aged-matched, AD and NDAN individuals synaptosomes revealed increased levels of ePS in NDAN, confirming damaged synapses engulfment. Our results suggest a higher efficiency of TREM2-induced phagocytic microglia in removing damaged synapses, underlying synaptic resilience in NDAN individuals.
Keywords: Alzheimer's disease; TREM2; microglia; phosphatidylserine; resilience; synapses.
© 2022 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.
Conflict of interest statement
The authors declare no competing financial interests.
Figures






Similar articles
-
Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.J Alzheimers Dis. 2020;78(4):1661-1678. doi: 10.3233/JAD-200716. J Alzheimers Dis. 2020. PMID: 33185603 Free PMC article.
-
Alzheimer's disease-associated R47H TREM2 increases, but wild-type TREM2 decreases, microglial phagocytosis of synaptosomes and neuronal loss.Glia. 2023 Apr;71(4):974-990. doi: 10.1002/glia.24318. Epub 2022 Dec 8. Glia. 2023. PMID: 36480007 Free PMC article.
-
Cognitive integrity in Non-Demented Individuals with Alzheimer's Neuropathology is associated with preservation and remodeling of dendritic spines.Alzheimers Dement. 2024 Jul;20(7):4677-4691. doi: 10.1002/alz.13900. Epub 2024 Jun 3. Alzheimers Dement. 2024. PMID: 38829680 Free PMC article.
-
Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.J Alzheimers Dis. 2022;87(1):51-81. doi: 10.3233/JAD-210607. J Alzheimers Dis. 2022. PMID: 35275527 Free PMC article. Review.
-
Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.Neuroscientist. 2023 Jun;29(3):302-316. doi: 10.1177/10738584211040786. Epub 2021 Sep 2. Neuroscientist. 2023. PMID: 34470515 Free PMC article. Review.
Cited by
-
Targeting synapse function and loss for treatment of neurodegenerative diseases.Nat Rev Drug Discov. 2024 Jan;23(1):23-42. doi: 10.1038/s41573-023-00823-1. Epub 2023 Nov 27. Nat Rev Drug Discov. 2024. PMID: 38012296 Review.
-
Sex differences in the microglial response to stress and chronic alcohol exposure in mice.Biol Sex Differ. 2025 Mar 4;16(1):19. doi: 10.1186/s13293-025-00701-y. Biol Sex Differ. 2025. PMID: 40038827 Free PMC article.
-
The Role of Insulin-like Growth Factor I in Mechanisms of Resilience and Vulnerability to Sporadic Alzheimer's Disease.Int J Mol Sci. 2023 Nov 17;24(22):16440. doi: 10.3390/ijms242216440. Int J Mol Sci. 2023. PMID: 38003628 Free PMC article. Review.
-
Disease-Modifying Effects of a Glial-targeted Inducible Nitric Oxide Synthase Inhibitor (1400W) in Mixed-sex Cohorts of a Rat Soman (GD) Model of Epilepsy.Res Sq [Preprint]. 2023 May 8:rs.3.rs-2883247. doi: 10.21203/rs.3.rs-2883247/v1. Res Sq. 2023. Update in: J Neuroinflammation. 2023 Jul 12;20(1):163. doi: 10.1186/s12974-023-02847-1. PMID: 37214912 Free PMC article. Updated. Preprint.
-
Drug screening targeting TREM2-TYROBP transmembrane binding.Mol Med. 2025 May 5;31(1):171. doi: 10.1186/s10020-025-01229-y. Mol Med. 2025. PMID: 40325411 Free PMC article.
References
-
- 2022 Alzheimer's disease facts and figures. Alzheimers Dement. 2022;18(4):700–89. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical